then henry waxman talking about the price of prescription drugs and what lawmakers can do. . . . . first of all, i'm an associate pastor at the public affairs american university and i am delighted to moderate this panel. today we're talking about private insurance subsidy first ever selection. i'm sure everyone in this room knows prior to 2014 the private insurance market in the individual market was the wild west. people would buy health insurance that was fully inadequate and extremely expensive but on the other hand you had people with employer-based insurance who were very happy with it as the model if you like what you have, you can keep it. the aca was very much focused on changing and improving the private individual market but also preserving the employer supported insurance market. today we will hear from for experts with unique and intricate knowledge about the development, implementation of the future of private insurance and individual market and elsewhere. you have their files and i won't read their list of expertise. first, we had joel michael, partner at mcdermitt,

. >> former california congressman henry waxman talks about his experiences drafting healthcare legislation. that set rules for prescription drug prices. he served as chair and ranking democrat on the house oversight committee. >> okay. so i like to get started with our lunch keynote address. my name is aaron behind. i'm an associate professor of medicine at harvard medical center. i run the program on regulation therapeutics and law which is an interdisciplinary research that focuses on intersections between pharmaceuticals and laws and regulations and clinical outcomes. we are the largest independent academic group in the country focusing on these matters and it's really my pleasure to be here and i really want to thank american university for putting together such a great program and the american society of law medicine and ethics in the other sponsors of this conference which has really been a fantastic conversation. and so, we spent a lot of time talking about the future of healthcare policymaking in our lunch session. it will be focused on one particular area which is the pharmaceutic

but with all due respect that was when henry waxman was chairman. i went to the floor of the house to make that announcement. it was fruitless if you can walk anything in all to say it is not a bipartisan. don't blame the president. played your of leadership because they carry the lion's share of this responsibility. >> a couple of things. eighteen hours of hearings with no witnesses, no associations from hospitals or nurses or doctors or advocates or cancer. >> no, no, no. >> i'll let you speak. no testimony from anybody. eighteen hours to deal. day you think that is the appropriate? in dealing in 18 hours? and with those individuals is that something to say we did a good job as members of congress? a thing that is wrong if you take away the preexisting conditions i think it is wrong. and at the end of the mandate talked to the heritage foundation one of the most republican groups out there. now they are running away. so why can we not sit down to allow witnesses and the advocates to give input? there is a legitimate group is supporting legislation

key players in helping, who helped establish this pharmaceutical marketplace in representative henry waxman who served as a member of the u.s. house of representatives for 40 years from 1975 to 2015, overseeing a number of important legislations, not only, but also the orphan drug act, prescription drug user act, the fda amendments act, and other pieces of legislation that helped establish the environment today. he currently serves as chairman at waxman strategy as well as an advisor at johns hopkins university bloomberg school of public health we are hoping he can talk with us today about his reputation as one of the main drivers in these important pieces of legislation. i'd like to let him give a few comments and i will get down to some discussion and hopefully have some time for audience q&a. please start thinking about your question. thank you. .mac. >> i am delighted to be with all of you today. i've looked over the schedule for the conference, and it looks like a fantastic conference. i know c-span is filming this, perhaps i can get a copy of the record of what has been said in the la

then henry waxman talking about the price of prescription drugs and what lawmakers can do. . . . .